Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 6th March 2020
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Product recall issued for Prednidale 5mg tablets
The recall is the result of microbial contamination of the product.

Defect found in single batch

The Veterinary Medicines Directorate (VMD) has announced that, on 4 March 2020, Dechra Ltd issued a product recall for a single batch of the product Prednidale 5mg tablets (Vm 10434/4009).

According to a statement, the recall is a result of microbial contamination of the product, and is for the following batch only:

Batch No Description Expiry Date
119072 Prednidale 5mg Tablets June 2021

Dechra Veterinary products has stated that it is in the process of contacting wholesale dealers and veterinary surgeons to assess their inventory as soon as possible and quarantine products subject to this recall.

For more information on the recall, please contact Ms Carol Morgan at carol.morgan@dechra.com.

Become a member or log in to add this story to your CPD history

Equine Disease Surveillance report released for Q4 2025

News Story 1
 The latest Equine Disease Surveillance report has been released, with details on equine disease from Q4 of 2025.

The report, produced by Equine Infectious Disease Surveillance, includes advice on rule changes for equine influenza vaccination.

Statistics and maps detail recent outbreaks of equine herpes virus, equine influenza, equine strangles and equine grass sickness. A series of laboratory reports provides data on virology, bacteriology, parasitology and toxicosis.

This issue also features a case study of orthoflavivus-associated neurological disease in a horse in the UK. 

Click here for more...
News Shorts
BSAVA announces 12th Edition of the Small Animal Formulary

The BSAVA has published an updated edition of its Small Animal Formulary, which includes new drug monographs and emergency drug doses for rabbits, rodents, birds and reptiles.

One of BSAVA's most trusted and widely used clinical resources, this 12th edition of the manual also includes seven new client information leaflets and information on drugs used for the management of urinary incontinence.

Part A of the Formulary, Canine and Feline, sees Fergus Allerton return as Editor-in-Chief, while Part B: Exotic Pets was edited by Joanna Hedley. For more information, visit the BSAVA website.